| 名稱 | CYP2C8*3 Reference Standard |
| 型號 | CBPA0040 |
| 報價 |  |
| 特點 | CYP2C8*3 Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 【連載-企業(yè)參考品】 急性淋巴細(xì)胞白血病的診斷參考品的選擇
- MYC診斷標(biāo)準(zhǔn)品
- 基于納米顆粒的組合免疫療法對致命性癌癥發(fā)起三重打擊
- 上海生科院發(fā)現(xiàn)PKM2抑制細(xì)胞凋亡的新機制
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 用藥指導(dǎo) > CBPA0040CYP2C8*3 Reference Standard
- 詳細(xì)內(nèi)容
| CBPA0040 | |
| Format | Genomic DNA |
| Description | CYP2C8 (Cytochrome P450 Family 2 Subfamily C Member 8) is a Protein Coding gene. Diseases associated with CYP2C8 include Drug Metabolism, Altered, Cyp2c8-Related and Osteonecrosis Of The Jaw. |
| Technical Data | |
| Gene | CYP2C8 |
| Mutation Type 1 | AA Change: p.R139K |
| DNA Change: NM_000770.3:c.416G>A | |
| Chr position (GRCh38): chr10:95067273G>A | |
| Mutation Type 2 | AA Change: p.K399R |
| DNA Change: NM_000770.3:c.1196A>G | |
| Chr position (GRCh38): chr10:95038992A>G | |
| Allelic Frequency | 100% |
| Zygosity | Homozygous |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. CYP2C8*3 Reference Standard p.R139K
Figure 2. CYP2C8*3 Reference Standard p.K399R |
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
